A novel metformin derivative showed improvement of lipid metabolism in obese rats with type 2 diabetes
- 10 March 2020
- journal article
- research article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 47 (8), 1382-1392
- https://doi.org/10.1111/1440-1681.13302
Abstract
In this study, we investigated the lipid metabolism regulatory activity of a novel metformin derivative (MD568) and its potential mechanism of action in obese rats with type 2 diabetes (T2DM). Previous gene chip analysis of 3T3‐L1 cells have shown that MD568 regulates the transcription of genes involved in the peroxisome proliferator‐activated receptor (PPAR) signalling pathway, fatty acid metabolism, and glycerolipid metabolism. In this study, obese T2DM rats were treated with MD568 (200 mg/kg) for 8 weeks. Results showed that MD568 significantly reduced the body weight gain, plasma glucose, insulin, total cholesterol, triglyceride, and low density lipoprotein cholesterol levels. MD568 treatment also improved the insulin resistance of obese T2DM model rats. In particular, in white adipose tissue, MD568 inhibited the excessive volume increment of adipose cells by down‐regulating the protein levels of CCAAT/enhancer binding protein‐α (C/EBP‐α) and PPAR‐γ, as well as the transcription of their target lipid metabolism‐related genes. In the liver, MD568 inhibited hepatic fatty lesions and interfered with hepatic gluconeogenesis by regulating the expression of lipid metabolism‐related genes and glycogen‐related kinases. In conclusion, our results suggested that the newly synthesized MD568 affected the maintenance of lipid homeostasis in obese type 2 diabetic rats.Keywords
This publication has 38 references indexed in Scilit:
- Two enzymes with redundant fructose bisphosphatase activity sustain gluconeogenesis and virulence in Mycobacterium tuberculosisNature Communications, 2015
- Circulating adipocyte fatty acid-binding protein induces insulin resistance in micein vivoObesity, 2015
- Metformin activates a duodenal Ampk–dependent pathway to lower hepatic glucose production in ratsNature Medicine, 2015
- Metformin: From Mechanisms of Action to TherapiesCell Metabolism, 2014
- Metformin trims fats to restore insulin sensitivityNature Medicine, 2013
- NAFLD in Asia—as common and important as in the WestNature Reviews Gastroenterology & Hepatology, 2013
- Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human LiverPPAR Research, 2010
- Dissection of mechanisms of Chinese medicinal formula Realgar- Indigo naturalis as an effective treatment for promyelocytic leukemiaProceedings of the National Academy of Sciences of the United States of America, 2008
- Adipocyte differentiation from the inside outNature Reviews Molecular Cell Biology, 2006
- Etiology of Insulin ResistanceAmerican Journal Of Medicine, 2006